I don’t think any of us investors thought it was necessarily...

I don’t think any of us investors thought it was necessarily over valued at the time but government legislation has been very slow and big Pharma/ Animal Health players have sat on the sidelines until they see a clearer path to commercialisation so the industry has sat in limbo with “ entrepreneurs “ wheeling and dealing and retail investors supporting.
Really comes down to whether you believe in the core patient / recreation propositions and if you do finding the best player most likely to go the journey and buckle up for the ride.